基础医学与临床 ›› 2016, Vol. 36 ›› Issue (6): 835-839.

• 研究论文 • 上一篇    下一篇

siRNA下调SNCG基因表达抑制膀胱癌细胞株5637的增殖和侵袭

陈志刚1,纪志刚2,石冰冰3,严维刚2,樊华2,李汉忠4   

  1. 1. 北京协和医学院协和医院
    2. 中国医学科学院 北京协和医学院 北京协和医院泌尿外科
    3. 中国医学科学院 北京协和医学院 北京协和医院
    4. 中国医学科学院北京协和医学院北京协和医院泌尿外科
  • 收稿日期:2016-03-22 修回日期:2016-04-20 出版日期:2016-06-05 发布日期:2016-05-27
  • 通讯作者: 石冰冰 E-mail:shibbpumch@126.com

siRNA-mediated downregulation of SNCG inhibits proliferation and invasiveness of bladder cancer cell line 5637

  • Received:2016-03-22 Revised:2016-04-20 Online:2016-06-05 Published:2016-05-27
  • Contact: Bing-bing SHI E-mail:shibbpumch@126.com

摘要: 目的 探讨突触核蛋白γ(SNCG)基因对膀胱癌细胞5637增殖和侵袭能力的影响。方法 设计并合成三对SNCG-siRNA序列,转染5637细胞后用RT-qPCR和Western blot检测SNCG的表达。最后,分别通过CCK-8增殖实验和侵袭实验评估5637细胞增殖和侵袭能力。结果 与膀胱癌细胞系T24、EJ和UMUC-3相比,5637细胞中SNCG表达水平最高(P<0.05);与空白和阴性对照组相比,三对SNCG-siRNA序列转染5637后均可抑制SNCG mRNA和SNCG蛋白的表达(P<0.05),但SNCG-siRNA-244组抑制效果最明显;实验组5637细胞的增殖受到明显抑制(P<0.05),且细胞的侵袭能力显著下降(P<0.05)。结论 通过特异性干扰SNCG基因的表达可抑制膀胱癌细胞5637的增值和侵袭,SNCG的siRNA序列可能成为膀胱癌治疗的新靶点。

关键词: 突触核蛋白γ, 膀胱癌, 5637细胞系, RNA干扰

Abstract: Objective To explore the effects of γ-synuclein (SNCG) on the proliferation and invasiveness of 5637 bladder cancer cells. Methods Three pairs of SNCG-specific siRNAs were designed and transfected into the 5637 cell lines, then the SNCG expression of the three siRNAs were assessed using RT-PCR and Western blot analysis, while the cell proliferation and invasiveness of the 5637 cells were evaluated by cell counting kit-8 (CCK-8) assay and transwell assay, respectively. Results The bladder cancer cell line 5637 was chose to use in next step due to its highest SNCG expression than that in cell lines EJ, T24 and UMUC-3 (P<0.05). Compared with NC and empty vector controls, all three SNCG siRNAs were observed to significantly inhibit SNCG expression (P<0.05), among which the lowest SNCG expression was detected in SNCG-siRNA-244. The proliferation and invasiveness of 5637 cell lines were both suppressed (P<0.05). Conclusions The proliferation and invasiveness of the bladder cancer cells could be decreased by specifically interferring the SNCG expression, SNCG siRNA may become as a novel target for biomedical therapy in bladder cancer.

Key words: Synuclein γ, bladder cancer, 5637 cell lines, RNA interference